首页 | 本学科首页   官方微博 | 高级检索  
     


Hepcidin‐25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients†
Authors:Karien van der Putten  Kim E. Jie  Daan van den Broek  Rob J. Kraaijenhagen  Coby Laarakkers  Dorine W. Swinkels  Branko Braam  Carlo A. Gaillard
Affiliation:1. Department of Internal Medicine, Meander MC Amersfoort, Amersfoort, The Netherlands;2. Department of Cardiology, UMC Utrecht, Utrecht, The Netherlands;3. Department of Nephrology and Hypertension, UMC Utrecht, Utrecht, The Netherlands;4. Department of Clinical Chemistry, Lange Land Hospital, Zoetermeer, The Netherlands;5. Department of Clinical Chemistry, Meander MC Amersfoort, Amersfoort, The Netherlands;6. Department of Clinical Chemistry, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;7. Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, AB, Canada;8. Department of Nephrology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Abstract:
Keywords:Heart failure  Chronic kidney disease  Anaemia  Iron  Hepcidin  Inflammation
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号